Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK

Source: Clinical & Laboratory Haematology, Volume 24, Number 4, August 2002 , pp. 263-265(3)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Document Type: Correspondence

DOI: http://dx.doi.org/10.1046/j.1365-2257.2002.00445.x

Publication date: 2002-08-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page